PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
1.680
-0.030 (-1.75%)
Nov 21, 2024, 10:40 AM EST - Market open
PharmaCyte Biotech Market Cap
PharmaCyte Biotech has a market cap or net worth of $12.90 million as of November 21, 2024. Its market cap has decreased by -33.50% in one year.
Market Cap
12.90M
Enterprise Value
-14.09M
1-Year Change
-33.50%
Ranking
Category
Stock Price
$1.68
Market Cap Chart
Since January 2, 2013, PharmaCyte Biotech's market cap has decreased from $17.00M to $12.90M, a decrease of -24.11%. That is a compound annual growth rate of -2.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 13.20M | -29.03% |
| Dec 29, 2023 | 18.60M | -66.12% |
| Dec 30, 2022 | 54.90M | 5.98% |
| Dec 31, 2021 | 51.80M | 219.75% |
| Dec 31, 2020 | 16.20M | -72.16% |
| Dec 31, 2019 | 58.20M | 35.03% |
| Dec 31, 2018 | 43.10M | -23.17% |
| Dec 29, 2017 | 56.10M | -57.11% |
| Dec 30, 2016 | 130.80M | 266.39% |
| Dec 31, 2015 | 35.70M | -72.56% |
| Dec 31, 2014 | 130.10M | 108.16% |
| Dec 31, 2013 | 62.50M | 267.65% |
| Jan 2, 2013 | 17.00M | - |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ekso Bionics Holdings | 15.11M |
| Microbot Medical | 15.02M |
| Minerva Neurosciences | 14.97M |
| Can-Fite BioPharma | 14.75M |
| Cingulate | 14.49M |
| Vivos Therapeutics | 14.11M |
| Psychemedics | 13.85M |
| Traws Pharma | 13.55M |